These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 20439578)
1. The looming rash of herpes zoster and the challenge of adult immunization. Donahue JG; Belongia EA Ann Intern Med; 2010 May; 152(9):609-11. PubMed ID: 20439578 [No Abstract] [Full Text] [Related]
2. The shingles vaccine. Why hasn't it caught on? The cost and other factors are to blame. Harv Health Lett; 2007 Aug; 32(10):1-2. PubMed ID: 17717891 [No Abstract] [Full Text] [Related]
3. [Herpes zoster and postherpetic neuralgia: advantages of the vaccination]. Cañada JL Rev Esp Quimioter; 2009 Nov; 22 Suppl 1():19-21. PubMed ID: 20084344 [No Abstract] [Full Text] [Related]
4. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia. Betts RF J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S143-7. PubMed ID: 18021866 [TBL] [Abstract][Full Text] [Related]
8. Vaccine against herpes zoster halves incidence in older people, finds study. Ramsey S BMJ; 2013 Apr; 346():f2349. PubMed ID: 23585074 [No Abstract] [Full Text] [Related]
9. Prevention and management of trigeminal herpes zoster and postherpetic neuralgia. Closmann JJ; Fielding CG; Pogrel MA Gen Dent; 2008; 56(6):563-6; quiz 567-8, 591-2. PubMed ID: 18810918 [TBL] [Abstract][Full Text] [Related]
10. Summaries for patients. Safety of the vaccine to prevent shingles. Ann Intern Med; 2010 May; 152(9):I20. PubMed ID: 20439568 [No Abstract] [Full Text] [Related]
11. [Prevention of herpes zoster by vaccination]. Kofoed K; Rønholt F; Gerstoft J; Sand C Ugeskr Laeger; 2011 Jan; 173(2):110-4. PubMed ID: 21219841 [TBL] [Abstract][Full Text] [Related]
12. [Herpes zoster and postherpetic neuralgia - prevention by vaccination?]. Wutzler P Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S90-4. PubMed ID: 19353479 [TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of vaccination against herpes zoster and postherpetic neuralgia: a critical review. Kawai K; Preaud E; Baron-Papillon F; Largeron N; Acosta CJ Vaccine; 2014 Mar; 32(15):1645-53. PubMed ID: 24534737 [TBL] [Abstract][Full Text] [Related]
14. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia. Holcomb K; Weinberg JM J Drugs Dermatol; 2006 Oct; 5(9):863-6. PubMed ID: 17039651 [TBL] [Abstract][Full Text] [Related]
15. Herpes zoster and postherpetic neuralgia: prevention and management. Fashner J; Bell AL Am Fam Physician; 2011 Jun; 83(12):1432-7. PubMed ID: 21671543 [TBL] [Abstract][Full Text] [Related]
18. Shingles (Herpes Zoster) Vaccine (Zostavax(®)): A Review in the Prevention of Herpes Zoster and Postherpetic Neuralgia. Keating GM BioDrugs; 2016 Jun; 30(3):243-54. PubMed ID: 27189459 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Pellissier JM; Brisson M; Levin MJ Vaccine; 2007 Nov; 25(49):8326-37. PubMed ID: 17980938 [TBL] [Abstract][Full Text] [Related]
20. Vaccination: a new option to reduce the burden of herpes zoster. Mick G Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):31-5. PubMed ID: 20192716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]